Carrick Therapeutics is dedicated to creating an innovative portfolio of first-in-class treatments that target multiple mechanisms of the most aggressive forms of cancer.
Carrick Therapeutics is an oncology-focused biopharmaceutical company leveraging its deep expertise to identify and develop highly differentiated novel therapies that address significant unmet needs.
CEO
Timothy Pearson
Sub segment
Pharmaceutical
Location
Dublin Ireland and Oxford, UK
